資源描述：
《冷循環(huán)射頻與手術(shù)治療肝癌的臨床研究》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、冷循環(huán)射頻與手術(shù)治療肝癌的臨床研宄【摘要】目的研究比較冷循環(huán)射頻與手術(shù)治療肝癌的療效、并發(fā)癥情況、住院花費(fèi)、住院天數(shù)及生活質(zhì)量。方法肝癌患者159例，分為兩組：腫瘤直徑彡、單發(fā)腫瘤44例，手術(shù)治療29例，冷循環(huán)射頻治療15例；腫瘤直徑〉患者115例，手術(shù)治療54例，冷循環(huán)射頻治療61例。冷循環(huán)射頻治療采用Col-tipRFTM系統(tǒng)，于超聲引導(dǎo)下將集束射頻治療針穿刺進(jìn)入腫瘤進(jìn)行治療。分組比較兩種治療的肝功能、AFP改變、并發(fā)癥情況、住院天數(shù)及花費(fèi)、生活質(zhì)量評(píng)分等。描述影像學(xué)變化。結(jié)果冷循環(huán)射頻治療對患者肝臟功能的破壞小于手術(shù)治療。冷循環(huán)射頻治療和手術(shù)治療對患者AFP水平的影響沒有明
2、顯差異。冷循環(huán)射頻治療并發(fā)癥發(fā)生率，住院天數(shù)及花費(fèi)低于手術(shù)治療，術(shù)后生存質(zhì)量高于手術(shù)治療。腫瘤直徑＜、單發(fā)腫瘤，冷循環(huán)射頻和手術(shù)1年生存率及中位生存時(shí)間沒有差異。結(jié)論相對于手術(shù)，冷循環(huán)射頻治療也是一種安全，有效的肝癌治療方法?！娟P(guān)鍵詞】射頻手術(shù)肝癌生活質(zhì)量ClinicalstudfradiofrequencyablyoftheapplicationoationandoperationontreatmentoflivercancerAbstractObjectiveToprobadiofrequencyablatercancerandcompareion.Methods1591iv
3、reincludedinthisstdintotwogroupsaccosofthEirtumorsandwere44casesinthegroumordiametersequalsreceivedoperationofrequencytreatmenthegroupwithtumour54casesreceivedopeedradiofrequencyopncytreatmentwerecotaneouslyorintraopguidanceofbundledneintothetreatmenteffect，complicationsrate，1ifequalityandhos
4、pitalizationexpensesofapplyingrion(RFA)totreatlivtowhichoftheoperatercancerpatientsweudy.TheyweredividerdingtothediameterhetherthEIrtumorswupofsolotumorwithtandlessthan，29casesandl5receivedradits，amongll5casesofdiametersmorethan，rationsand61receiverationswerefrequenductedeitherpercuerativelyu
5、ndertheeedleswerepuncturedintothetumorsandperformedradiofrequencytreatmentswithtreatmentfrequencyof480kHz，treatmenttimedataofliverfunotion,AFP，adiofrequencyablatercancerandcompareion.Methods1591ivreincludedinthisstdintotwogroupsaccosofthEirtumorsandwere44casesinthegroumordiametersequalsreceiv
6、edoperationofrequencytreatmenthegroupwithtumour54casesreceivedopeedradiofrequencyopncytreatmentwerecotaneouslyorintraopguidanceofbundledneintothetreatmenteffect，complicationsrate，1ifequalityandhospitalizationexpensesofapplyingrion(RFA)totreatlivtowhichoftheoperatercancerpatientsweudy.Theywere
7、dividerdingtothediameterhetherthEIrtumorswupofsolotumorwithtandlessthan，29casesandl5receivedradits，amongll5casesofdiametersmorethan，rationsand61receiverationswerefrequenductedeitherpercuerativelyundertheeedleswerepuncturedintothetumorsandperf
